Loading…

Loss of the tRNA

To investigate the presence/absence of the gene as a marker for genetic predisposition to Type 2 diabetes mellitus (T2DM). We enrolled 122 patients diagnosed with T2DM and 77 non-diabetic individuals. We evaluated clinical and biochemical parameters (body mass index, hypertension, cholesterol levels...

Full description

Saved in:
Bibliographic Details
Published in:Biomarkers in medicine 2019-03, Vol.13 (4), p.259-266
Main Authors: Yang, Pablo, Beltramo, Dante Miguel, de Pouplana, Lluís Ribas, Soria, Néstor Walter, Torres, Adrian Gabriel
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 266
container_issue 4
container_start_page 259
container_title Biomarkers in medicine
container_volume 13
creator Yang, Pablo
Beltramo, Dante Miguel
de Pouplana, Lluís Ribas
Soria, Néstor Walter
Torres, Adrian Gabriel
description To investigate the presence/absence of the gene as a marker for genetic predisposition to Type 2 diabetes mellitus (T2DM). We enrolled 122 patients diagnosed with T2DM and 77 non-diabetic individuals. We evaluated clinical and biochemical parameters (body mass index, hypertension, cholesterol levels, glycosylated hemoglobin, triglycerides, etc.), and performed a genotypic profiling of by polymerase chain reaction analyses. Approximately one third of the population lacked . We did not observe a statistically significant association between the presence/absence of and T2DM. The genotypic distribution of in our population was consistent to that reported by others. This gene failed as a marker for T2DM predisposition.
doi_str_mv 10.2217/bmm-2018-0322
format article
fullrecord <record><control><sourceid>futurescience</sourceid><recordid>TN_cdi_futurescience_futuremedicine_10_2217_bmm_2018_0322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2217_bmm_2018_0322</sourcerecordid><originalsourceid>FETCH-futurescience_futuremedicine_10_2217_bmm_2018_03223</originalsourceid><addsrcrecordid>eNpjYBA1NNAzMjI010_KzdU1MjC00DUwNjJiYuA0NDc1ArLNDVngbDNjDgau4uIsAwNTc3MzI04GAZ_84mKF_DSFkoxUhZIgP0ceBta0xJziVF4ozc1g6eYa4uyhm1ZaUlqUWpycmZqXnBoP4eWmpmQmZ-alxhsaxIOcEA90QjzICfEgJxhTohcAwbc8HA</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Loss of the tRNA</title><source>Open Access: PubMed Central</source><creator>Yang, Pablo ; Beltramo, Dante Miguel ; de Pouplana, Lluís Ribas ; Soria, Néstor Walter ; Torres, Adrian Gabriel</creator><creatorcontrib>Yang, Pablo ; Beltramo, Dante Miguel ; de Pouplana, Lluís Ribas ; Soria, Néstor Walter ; Torres, Adrian Gabriel</creatorcontrib><description>To investigate the presence/absence of the gene as a marker for genetic predisposition to Type 2 diabetes mellitus (T2DM). We enrolled 122 patients diagnosed with T2DM and 77 non-diabetic individuals. We evaluated clinical and biochemical parameters (body mass index, hypertension, cholesterol levels, glycosylated hemoglobin, triglycerides, etc.), and performed a genotypic profiling of by polymerase chain reaction analyses. Approximately one third of the population lacked . We did not observe a statistically significant association between the presence/absence of and T2DM. The genotypic distribution of in our population was consistent to that reported by others. This gene failed as a marker for T2DM predisposition.</description><identifier>ISSN: 1752-0363</identifier><identifier>EISSN: 1752-0371</identifier><identifier>DOI: 10.2217/bmm-2018-0322</identifier><language>eng</language><publisher>Future Medicine Ltd</publisher><subject>biomarker ; gene translation ; genotypic profiling ; insulin ; PCR ; T2DM ; tRNA ; tRNA gene ; tRNA-Lys-CUU ; Type 2 diabetes mellitus</subject><ispartof>Biomarkers in medicine, 2019-03, Vol.13 (4), p.259-266</ispartof><rights>2019 Future Medicine Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Yang, Pablo</creatorcontrib><creatorcontrib>Beltramo, Dante Miguel</creatorcontrib><creatorcontrib>de Pouplana, Lluís Ribas</creatorcontrib><creatorcontrib>Soria, Néstor Walter</creatorcontrib><creatorcontrib>Torres, Adrian Gabriel</creatorcontrib><title>Loss of the tRNA</title><title>Biomarkers in medicine</title><description>To investigate the presence/absence of the gene as a marker for genetic predisposition to Type 2 diabetes mellitus (T2DM). We enrolled 122 patients diagnosed with T2DM and 77 non-diabetic individuals. We evaluated clinical and biochemical parameters (body mass index, hypertension, cholesterol levels, glycosylated hemoglobin, triglycerides, etc.), and performed a genotypic profiling of by polymerase chain reaction analyses. Approximately one third of the population lacked . We did not observe a statistically significant association between the presence/absence of and T2DM. The genotypic distribution of in our population was consistent to that reported by others. This gene failed as a marker for T2DM predisposition.</description><subject>biomarker</subject><subject>gene translation</subject><subject>genotypic profiling</subject><subject>insulin</subject><subject>PCR</subject><subject>T2DM</subject><subject>tRNA</subject><subject>tRNA gene</subject><subject>tRNA-Lys-CUU</subject><subject>Type 2 diabetes mellitus</subject><issn>1752-0363</issn><issn>1752-0371</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpjYBA1NNAzMjI010_KzdU1MjC00DUwNjJiYuA0NDc1ArLNDVngbDNjDgau4uIsAwNTc3MzI04GAZ_84mKF_DSFkoxUhZIgP0ceBta0xJziVF4ozc1g6eYa4uyhm1ZaUlqUWpycmZqXnBoP4eWmpmQmZ-alxhsaxIOcEA90QjzICfEgJxhTohcAwbc8HA</recordid><startdate>20190301</startdate><startdate>20190301</startdate><enddate>20190301</enddate><enddate>20190301</enddate><creator>Yang, Pablo</creator><creator>Beltramo, Dante Miguel</creator><creator>de Pouplana, Lluís Ribas</creator><creator>Soria, Néstor Walter</creator><creator>Torres, Adrian Gabriel</creator><general>Future Medicine Ltd</general><scope/></search><sort><creationdate>20190301</creationdate><title>Loss of the tRNA</title><author>Yang, Pablo ; Beltramo, Dante Miguel ; de Pouplana, Lluís Ribas ; Soria, Néstor Walter ; Torres, Adrian Gabriel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-futurescience_futuremedicine_10_2217_bmm_2018_03223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>biomarker</topic><topic>gene translation</topic><topic>genotypic profiling</topic><topic>insulin</topic><topic>PCR</topic><topic>T2DM</topic><topic>tRNA</topic><topic>tRNA gene</topic><topic>tRNA-Lys-CUU</topic><topic>Type 2 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Pablo</creatorcontrib><creatorcontrib>Beltramo, Dante Miguel</creatorcontrib><creatorcontrib>de Pouplana, Lluís Ribas</creatorcontrib><creatorcontrib>Soria, Néstor Walter</creatorcontrib><creatorcontrib>Torres, Adrian Gabriel</creatorcontrib><jtitle>Biomarkers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Pablo</au><au>Beltramo, Dante Miguel</au><au>de Pouplana, Lluís Ribas</au><au>Soria, Néstor Walter</au><au>Torres, Adrian Gabriel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loss of the tRNA</atitle><jtitle>Biomarkers in medicine</jtitle><date>2019-03-01</date><date>2019-03-01</date><risdate>2019</risdate><risdate>2019</risdate><volume>13</volume><issue>4</issue><spage>259</spage><epage>266</epage><pages>259-266</pages><issn>1752-0363</issn><eissn>1752-0371</eissn><abstract>To investigate the presence/absence of the gene as a marker for genetic predisposition to Type 2 diabetes mellitus (T2DM). We enrolled 122 patients diagnosed with T2DM and 77 non-diabetic individuals. We evaluated clinical and biochemical parameters (body mass index, hypertension, cholesterol levels, glycosylated hemoglobin, triglycerides, etc.), and performed a genotypic profiling of by polymerase chain reaction analyses. Approximately one third of the population lacked . We did not observe a statistically significant association between the presence/absence of and T2DM. The genotypic distribution of in our population was consistent to that reported by others. This gene failed as a marker for T2DM predisposition.</abstract><pub>Future Medicine Ltd</pub><doi>10.2217/bmm-2018-0322</doi></addata></record>
fulltext fulltext
identifier ISSN: 1752-0363
ispartof Biomarkers in medicine, 2019-03, Vol.13 (4), p.259-266
issn 1752-0363
1752-0371
language eng
recordid cdi_futurescience_futuremedicine_10_2217_bmm_2018_0322
source Open Access: PubMed Central
subjects biomarker
gene translation
genotypic profiling
insulin
PCR
T2DM
tRNA
tRNA gene
tRNA-Lys-CUU
Type 2 diabetes mellitus
title Loss of the tRNA
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T04%3A28%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-futurescience&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loss%20of%20the%20tRNA&rft.jtitle=Biomarkers%20in%20medicine&rft.au=Yang,%20Pablo&rft.date=2019-03-01&rft.volume=13&rft.issue=4&rft.spage=259&rft.epage=266&rft.pages=259-266&rft.issn=1752-0363&rft.eissn=1752-0371&rft_id=info:doi/10.2217/bmm-2018-0322&rft_dat=%3Cfuturescience%3E10_2217_bmm_2018_0322%3C/futurescience%3E%3Cgrp_id%3Ecdi_FETCH-futurescience_futuremedicine_10_2217_bmm_2018_03223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true